Chemoinformaics analysis of 4,8,12,16-TETRAMETHYLHEPTADECAN-4-OLIDE
Molecular Weight | 324.549 | nRot | 12 |
Heavy Atom Molecular Weight | 284.229 | nRig | 6 |
Exact Molecular Weight | 324.303 | nRing | 1 |
Solubility: LogS | -6.799 | nHRing | 1 |
Solubility: LogP | 7.327 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 63 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 40 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 63.3457 |
nHD | 0 | BPOL | 42.7323 |
QED | 0.382 |
Synth | 3.621 |
Natural Product Likeliness | 1.582 |
NR-PPAR-gamma | 0.02 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.58 |
Pgp-sub | 0 |
HIA | 0.002 |
CACO-2 | -4.593 |
MDCK | 0.0000179 |
BBB | 0.3 |
PPB | 0.980387 |
VDSS | 1.384 |
FU | 0.0244767 |
CYP1A2-inh | 0.212 |
CYP1A2-sub | 0.192 |
CYP2c19-inh | 0.332 |
CYP2c19-sub | 0.693 |
CYP2c9-inh | 0.389 |
CYP2c9-sub | 0.838 |
CYP2d6-inh | 0.103 |
CYP2d6-sub | 0.038 |
CYP3a4-inh | 0.445 |
CYP3a4-sub | 0.155 |
CL | 8.495 |
T12 | 0.094 |
hERG | 0.02 |
Ames | 0.004 |
ROA | 0.01 |
SkinSen | 0.958 |
Carcinogencity | 0.067 |
EI | 0.322 |
Respiratory | 0.506 |
NR-Aromatase | 0.012 |
Antiviral | Yes |
Prediction | 0.562153 |